Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Posted On Wednesday, February 19, 2025
Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
Posted On Wednesday, February 19, 2025
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Tuesday, February 18, 2025
Aptose Announces Reverse Share Split
Posted On Tuesday, February 18, 2025
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
Posted On Tuesday, February 18, 2025
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
Posted On Tuesday, February 18, 2025
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
Posted On Tuesday, February 18, 2025
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
Posted On Tuesday, February 18, 2025
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
Posted On Tuesday, February 18, 2025
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
Posted On Tuesday, February 18, 2025
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
Posted On Tuesday, February 18, 2025
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
Posted On Tuesday, February 18, 2025
Highsman Releases HIT STICKS in MA, Creating an Entirely New Single-Use Cannabis Product Category
Posted On Tuesday, February 18, 2025
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
Posted On Tuesday, February 18, 2025
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
Posted On Tuesday, February 18, 2025
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
Posted On Tuesday, February 18, 2025
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
Posted On Tuesday, February 18, 2025
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, February 18, 2025
Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Posted On Tuesday, February 18, 2025
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
Posted On Tuesday, February 18, 2025
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
Posted On Tuesday, February 18, 2025
Windtree Therapeutics, Inc. Announces Reverse Stock Split
Posted On Tuesday, February 18, 2025
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
Posted On Tuesday, February 18, 2025
ALX Oncology to Host Virtual R&D Day on March 5, 2025
Posted On Tuesday, February 18, 2025
ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
Posted On Tuesday, February 18, 2025

Print